US Patent Family Members and Approved Drugs for Japan Patent: 2001510163
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: JP2001510163
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 6,667,041 | 2017-07-15 | onabotulinumtoxina | Allergan, Inc. | BOTOX COSMETIC |
| 7,001,602 | 2017-07-15 | onabotulinumtoxina | Allergan, Inc. | BOTOX COSMETIC |
| 7,429,387 | 2017-07-15 | onabotulinumtoxina | Allergan, Inc. | BOTOX COSMETIC |
| 7,449,192 | 2017-07-15 | onabotulinumtoxina | Allergan, Inc. | BOTOX COSMETIC |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
